What's new

Human medicines European public assessment report (EPAR): Rozlytrek, entrectinib, Date of authorisation: 31/07/2020, Revision: 9, Status: Authorised

Human medicines European public assessment report (EPAR): Rozlytrek, entrectinib, Date of authorisation: 31/07/2020, Revision: 9, Status: Authorised

Mar 14, 2025 - 15:07
 0
Human medicines European public assessment report (EPAR): Rozlytrek, entrectinib, Date of authorisation: 31/07/2020, Revision: 9, Status: Authorised
Human medicines European public assessment report (EPAR): Rozlytrek, entrectinib, Date of authorisation: 31/07/2020, Revision: 9, Status: Authorised
Read More

Tags:

Previous Article

Pliant, Acelyrin resort to ‘poison pills’ as threat of Concentra buyout looms

Next Article

Veterinary medicines European public assessment report (EPAR): Mhyosphere PCV ID...

Related Posts

Human medicines European public assessment report (EPAR): Bretaris Genuair, aclidinium bromide, Date of authorisation: 20/07/2012, Revision: 20, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 25, 2025  0

Checklist for the submission of Type IA and Type IB (wi...

Feb 18, 2025  0

EMEA-003498-PIP01-23

EMEA-003498-PIP01-23

Mar 7, 2025  0